Download crc sabah newsletter - Clinical Research Centre

Issue 3 : September– December 2013
CRC SABAH NEWSLETTER
Inside This Issue
Welcome to Issue 3 of CRC Sabah
Newletter
Investigator Initiated Research (IIR)
and industry Sponsored Research
(ISR) updates
Activities and Photo Gallery
Contact Us
Upcoming Events
WELCOME TO ISSUE 3 OF CRC NEWSLETTER
Warmest Greeting from CRC Sabah! Welcome 2014, and Happy
New Year! As we begin this New Year, we hope that 2014 will
bring bigger and better things for the Clinical Research Centre
(CRC).
In This issue, we want to announce the upcoming workshop
organized by CRC Sabah for the year 2014.
1. Good Clinical Practice (GCP) Workshop collaboration
with Clinical Research Malaysia (CRM)
19th – 21st Feb 2014, Sabah Women and Children Hospital.
2. Sabah Good Clinical Practice (GCP) Workshop
CRC’s OBJECTIVE
1. To promote a culture of
research
among
healthcare
workers in Sabah.
26th – 28th Mar 2014, Hospital Queen Elizabeth II.
3. Basic to Intermediate Medical Biostatistics Using SPSS
Workshop 2014
14 – 17 April 2014, School Of Medical, University Malaysia
Sabah (UMS).
4. Advanced Medical Biostatistics Using SPSS Workshop
2014
2 – 6 Jun 2014, School Of Medical, University Malaysia Sabah
(UMS).
2. To disseminate skills in
Methodology, Statistical tools, and
techniques in designing and
conducting clinical trials.
3. To provide healthcare workers
the principle of methodology and
biostatistics in clinical research
Grab this opportunity and never stop Learning! See you there!
CRC’s Vision
 To be a leading clinical research institution in Asia
CRC’s Mission
 To improve patients health outcomes through ethical
and quality clinical research.
ISSUE 3: September – December 2013
CRC Sabah Newsletter
MESSAGE AND RESOLUTION CRC SABAH HEAD 2014
First and foremost, I would like to congratulate the editorial team for their success in publishing the third edition of CRC Sabah Newsletter.
This latest edition marks another important milestone for CRC Sabah.
It has been more than 5 years since the inception of CRC Sabah. Since then we have seen the number of industry-sponsored research and
investigator-initiated research activities increase.
CRC Sabah is committed to promote a research culture at all levels of the MOH in Sabah. In order to achieve this CRC Sabah has visited 13
district hospitals in the north, west and interior of Sabah. These visit helped to promote CRC services and resolve problems with regard to
research matters in the districts. CRC Sabah will cover the hospitals in eastern Sabah this year.
In addition, CRC will organize numerous courses such as a Biostatistics Workshop, Research Proposal Development workshop and Good
Clinical Practice workshop. This is to disseminate information to healthcare providers the proper way of conducting research. We hope to
strengthen research capability through long lasting collaborations with local institutions and other hospitals. Additionally, we hope to facilitate
research activities with emphasis on quality research from these collaborations.
Finally, I wish to thank all the staff of CRC Sabah for working tirelessly to achieve these objectives. Enjoy reading.
Datuk Dr Jayaram Menon
Head of CRC Sabah
Hospital Queen Elizabeth
Thank you for the opportunity to say a few words.
Congratulations to the editorial team from CRC Likas for producing the third edition of CRC Sabah Newsletter.
2013 has seen a number of successful industry sponsored research (ISR), which is the main focus at our centre. A Good Clinical Practice
(GCP) Workshop will be held from 19-21 February 2014 in Likas Hospital itself, specially organised by Clinical Research Malaysia (CRM) in
collaboration with CRC Sabah.
We hope to increase awareness in clinical research as well as to cultivate the research culture and have responsible investigators to conduct
studies of high quality. We are committed to assist all the disciplines which are interested to conduct research, within our capabilities. Last
but not least, I wish everyone a happy new year!
Dr Flora Chong Li Tze
Head of CRC Hospital Likas
ISSUE 3: September – December 2013
CRC Sabah Newsletter
Table 1: Investigator Initiated Research (IIR) Approved by MREC
NO
NMRR ID
STUDY TITLE
1
NMRR-13-425-14815
Substance use among psychiatric inpatients in Duchess of Kent Hospital,
Sandakan
2
NMRR-13-354-16253
Amalan Gaya Hidup Sihat di Kalangan Paramedik Hospital Kuala Penyu
3
NMRR-13-546-16814
4
NMRR-12-134-13359
5
NMRR-13-677-15713
Attitude and Perceptions of Healthcare Professionals towards Clinical
Pharmacy Services in Lahad Datu Hospital
Mengkaji faktor-faktor yang mempengaruhi kesan psikososial terhadap
pesakit talasemia.
Determining the Aetiology of Non-Malarial Acute Febrile Illness in Sabah
6
7
NMRR-13-574-16749
NMRR-13-858-14725
8
NMRR-13-800-15838
9
10
NMRR-13-804-16974
NMRR-13-813-17173
11
NMRR-13-842-17444
12
NMRR-13-800-15838
13
NMRR-13-804-16974
NMRR-13-842-17444
CD44s expression in soft tissue sarcomas, a potential prognostic marker
The study of b-Thalassemia trait among adolescents in sabah, east malaysia,
a population study
Survey on knowledge of psychotropic medications among paramedics and
nurses in Hospital Mesra Bukit Padang
Risk factors of pacemaker Implantation Infection: a single centre experience.
Amalan kepatuhan rawatan tibi secara dot dalam kalangan pesakit tibi di Klinik
kawalan tibi dan kusta Lahad Datu, Sabah.
Census on patients completing one year treatment of adjuvant Trastuzumab
from January 2012 till July 2013 at Hospital Likas, Kota Kinabalu, Sabah.
Survey on knowledge of psychotropic medications among paramedics and
nurses in Hospital Mesra Bukit Padang
Risk factors of pacemaker Implantation Infection: a single centre experience.
Census on patients completing one year treatment of adjuvant Trastuzumab
from January 2012 till July 2013 at Hospital Likas, Kota Kinabalu, Sabah.
A Randomized Controlled Study on Compliance towards MASA 1956 among
Retail Pharmacies in Sabah
14
15
NMRR-13-639-16766
16
NMRR-13-649-16823
A Pilot Study of Barriers Towards Quit Smoking among Participants of Quit
Smoking Clinic in Hospital Duchess of Kent, Sandakan.
17
NMRR-13-732-16497
18
NMRR-13-843-16712
19
NMRR-13-906-16967
Implementation of hospital information system (his) in Malaysian public
hospitals
Human-animal Exposure Study in Malaysia, Kinabatangan District, Sabah State,
Malaysia
Epidemiological and Clinical Profile of Transfusion Dependent Thalassemia
Patient in Sabah
STUDY SITE
Duchess of Kent
Hospital,
Sandakan
Kuala Penyu
Hospital
Lahad Datu
Hospital
QEH I/ Keningau/
HWKKS
QEH I/ HWKKS/
Kudat/Kota
Merudu
QEH I
QEH I
HMBP
QEH II
Jabatan Pesakit
Luar, Klinik
Kesihatan Lahad
Datu
HWKKS
HMBP
QEH II
HWKKS
Cawangan
Penguatkuasa
Farmasi, Jabatan
Kesihatan Negeri
Sabah.
HDOK
Kunak/ Keningau/
Lahad datu Hosp
JKNS
QEH I/ HDOK
ISSUE 3: September – December 2013
CRC Sabah Newsletter
20
NMRR-13-119218473
21
NMRR-13-642-17166
22
NMRR-13-875-17115
Neonatal jaundis teruk: kegagalan ibu mematuhi rujukan pemeriksaan serum
bilirubin mengakibatkan peningkatan kes neonatal jaundis teruk di daerah
Sandakan.
Outcome of Pharmacist Intervention on Medication Compliance among
Hemodialysis patients in Lahad Datu Hospital
Fluoride enamel opacities among 16-year-old school children in Malaysia
23
NMRR-13-962-17898
Cardiovascular risk management among primary care patients in Malaysia
24
NMRR-13-915-16059
25
26
27
NMRR-13-373-14897
NMRR-13-891-17366
NMRR-13-904-16833
28
29
NMRR-13-100115684
NMRR-13-883-16902
30
NMRR-13-725-16306
31
NMRR-13-599-16838
32
33
NMRR-13-551-16402
NMRR-13-106617354
A retrospective Assessment of Integrated-Quit-Smoking-Service in Primary
Healthcare Setting
Current status of Drug Information Centers in Malaysia
DEB-only All Comers Registry
HER-2 Expression and Amplification in locally advanced, metastatic or
unresectable gastric and gastroesophageal junction adenocarcinoma
population in PPNR, Sabah.
The Effectiveness of Online Training for Interpretation of Video fluoroscopy of
Swallowing Study Among Speech-Language Therapists in Malaysia.
Program Pengubatan Beramai-ramai (MDA) Filariasis Limfatik Penduduk Di
Kampung Keramat, Beluran, Sabah.
Isolation of methicillin-resistant staphylococcus aureus (mrsa) from nasal swab
in heterogenous studied group population
Medication therapy optimization clinic (mtoc) dyslipidemia: evaluation of a
pharmacist-managed lipid clinic that uses a novel lipid titration protocol
Liver impairment in paediatric thalassaemia patients on deferasirox
International multicentre prevalence study on sepsis
34
NMRR-13-108817518
NMRR-13-109216922
NMRR-13-102314660
NMRR-13-119517901
35
36
37
38
NMRR-13-116718340
Psychometric evaluation of the malay version of alcohol use disorder
identification test (audit-m)
Physician's satisfaction with the performance of pharmacists in pharmacistinvolved anticoagulation clinic, Queen Elizabeth Hospital II
Identifying psychosocial and economic risk factors and quantifying the costs of
age-related cognitive impairment: implications of population aging in Malaysia
Pharmacist-initiated lung function screening using validated copd-ps
questionnaire followed by vitalograph copd-6 to detect the impaired lung
function in people at risk of developing COPD in primary health care setting.
Kajian dalam dokumentasi penjagaaan pesakit yang menyebabkan bebanan di
kalangan jururawat di Queen Elizabeth Hospital II
Pejabat Kesihatan
Kawasan
Sandakan
Lahad Datu Hosp
Oral Health
Division, MOH,
JKNS
Klinik Kesihatan
Luyang
Klinik Kesihatan
Luyang
JKNS
QEH II
HWKKS
QEH I/ HDOK
Pejabat Kesihatan
Kawasan Beluran
QEH I
Tawau Hospital
HDOK
QEH I/ QEH II/
Keningau/ HDOK/
Lahad Datu
Klinik Kesihatan
Penampang
QEH II
QEH I
Klinik Kesihatan
Luyang
QEH II
ISSUE 3: September – December 2013
CRC Sabah Newsletter
Table 2 : Ongoing Industry Sponsored Research (ISR) In Sabah. August – December 2013
NO
NMRR ID
Department/
Unit
Site
Institution
NMRR-081377-2750
NMRR-09200-3744
Oncology
HWKKS
Rheumatology
HQE I
3
NMRR-09401-4109
Rheumatology
HQE I
4
NMRR-09654-4406
Oncology
HWKKS
5
NMRR-10628-5357
Nephrology
HQE I
6
NMRR-10198-5403
Cardiology
HQE II
7
NMRR-101193-5556
Rheumatology
HQE I
8
NMRR-10706-6055
Endocrinology
HQE I
9
NMRR-10753-6795
PSY
HMBP
10
NMRR-10983-7456
Rheumatology
HQE I
11
NMRR-101203-7871
Rheumatology
HQE I
12
NMRR-11395-9024
Oncology
HWKKS
13
NMRR-11991-9842
Oncology
HWKKS
1
2
Research
Title
Multicenter, randomized, double-blind, Phase III trial to
investigate the efficacy and safety of oral BIBF 1120 plus
standard pemetrexed therapy compared to placebo plus
A Long-Term, Open-Label Follow-Up Study of Tofacitinib
(CP-690,550) For Treatment of Rheumatoid Arthritis.
Protocol No. A3921024
A Multicenter, Randomized, Double-blind, Placebocontrolled Trial of Golimumab, an Anti-TNFá Monoclonal
Antibody, Administered Intravenously, in Subjects with
Active Rheumatoid Arthritis Despite Methotrexate
Therapy.
Research
Subtype
Interventional Study :
Clinical Trial
A Randomized, Multicenter, Open-Label, Phase 3 Study
to Compare the Efficacy and Safety of Panitumumab and
Cetuximab in Subjects with Previously Treated, WildType KRAS, Metastatic Colorectal Cancer
Phase
IIb/III
Clinical
Study
Protocol
- Chronic Renal Failure (Primary Glomerular
Disease/Nephrosclerosis) Prospective observational LongitudinAl Registry oF
patients with stable coronary arterY disease.
Interventional Study :
Clinical Trial
An observational study of Rheumatoid arthritis patients
on adalimumab to Evaluate quality of LIfe Variables,
Effects on work productivity and functional outcomes in
Malaysia
A Phase III, multicentre, international, randomised,
parallel group, double blind cardiovascular safety study
of BI 10773 (10 mg and 25 mg administered orally once
daily) compared to usual care in type 2 diabetes mellitus
patients with increased cardiovascular risk.
A Randomized, Double-blind, Placebo-Controlled,
Parallel-Group Study of Paliperidone Palmitate
Evaluating Time to Relapse in Subjects With
Schizoaffective Disorder
A Phase 3, Multicenter, Randomized, Double-Blind,
Placebo-Controlled Study to Evaluate the Efficacy and
Safety of Subcutaneous LY2127399 in Patients with
Systemic Lupus Erythematosus (SLE)
A randomized, double-blind, parallel-group study of
safety and the effect on clinical outcome of Tocilizumab
SC versus placebo SC in combination with traditional
disease modifying anti-rheumatic drugs (DMARDs) in
patients with moderate to severe active rheumatoid
arthritis
A Open-Label Study of Abiraterone Acetate in Subjects
with Metastatic Castration-Resistant Prostate Cancer
Who Have Progressed After Taxane-Based
Chemotherapy
A Randomized, Double-blind, Placebo-controlled Study
to Evaluate the Long-term Safety and Efficacy of
Darbepoetin Alfa Administered at 500 ìg Once-Every-3-
Interventional Study :
Clinical Trial
Interventional Study :
Clinical Trial
Interventional Study :
Clinical Trial
Observational Study :
Patient registry/Clinical
database
Observational Study :
Clinical Economics
Interventional Study :
Clinical Trial
Interventional Study :
Clinical Trial
Interventional Study :
Clinical Trial
Interventional Study :
Clinical Trial
Interventional Study :
Clinical Trial
Interventional Study :
Clinical Trial
ISSUE 3: September – December 2013
14
NMRR-11-
CRC Sabah Newsletter
Weeks in Anemic Subjects With Advanced Stage Nonsmall Cell Lung Cancer Receiving Multi-cycle
Chemotherapy
Scientific Partnership for HER2 Testing Excellence
(SPHERE) Clinical Audit
Pathology
HQE I
ENT/
Haematology/
Oncology
Oncology
HQE I/
HWKKS
Cancer and its economic impact on household in the
Asean countries (action study)
HWKKS
A phase iii prospective, two-cohort non-randomized,
multi-centre, multinational, open label study to assess
the safety of assisted- and self-administered
subcutaneous Trastuzumab as therapy in patients with
operable her2-positive early breast cancer
A Phase 3, Safety and Efficacy Study of
Boceprevir/Peginterferon Alfa-2a/ribavirin in Chronic
HCV Genotype 1 IL28B CC Subjects
A hospital-based, retrospective study of the burden of
community acquired pneumonia in children aged <5
years in Indonesia, Malaysia, South Korea and Vietnam
A Multi-centre, Randomised, Double-blind, Placebocontrolled Trial to Determine the Efficacy and Safety of
Hepar-P Capsule for the Treatment of Non-Alcoholic
Fatty Liver Disease (NAFLD)
A Phase 3b, Multicenter, Open-Label Study to Evaluate
the Long-Term Safety and Efficacy of Subcutaneous
LY2127399 in Patients with Systemic Lupus
Erythematosus (SLE) (ILLUMINATE-X)
A randomized, double-blind, double-dummy, 4-week
treatment, parallel-group study to evaluate the efficacy
and safety of two doses of Mometasone furoate
delivered via Concept1 or Twisthaler® in adult and
adolescent patients with persistent asthma
A randomized, double-blind placebo-controlled study of
the maintenance of efficacy of Atanercept plus
dmard(s) compared with dmard(s) alone in subjects
with rheumatoid arthritis after achieving an adequate
response with etanercept plus dmard(s).
A randomized, multicenter, adaptive phase ii/iii study
to evaluate the efficacy and safety of Trastuzumab
Emtansine (t-dm1) versus Taxane (Docetaxel or
Paclitaxel) in patients with previously treated locally
advanced or metastatic her2-positive gastric cancer,
including adenocarcinoma of the Gastroesophageal
junction
A Double-blind, Randomized, Placebo-controlled,
Multicenter Study Assessing the Impact of Additional
LDL-Cholesterol Reduction on Major Cardiovascular
Events When AMG 145 is Used in Combination With
Statin Therapy In Patients with Clinically Evident
Cardiovascular Disease
A randomized, phase iii, multicenter, double-blind,
placebo-controlled study evaluating the efficacy and
safety of Onartuzumab (metmab) in combination with
5-fluorouracil, folinic acid, and oxaliplatin (mfolfox6) in
865-9930
15
NMRR-11800-10093
16
NMRR-111020-10569
17
NMRR-111010-10697
Gastroenterology
HQE I
18
NMRR-12-5010793
Pediatrics
HWKKS
19
NMRR-12181-10976
Gastroenterology
HQE I
20
NMRR-12426-11014
Rheumatology
HQE I
21
NMRR-12493-11112
Respiratory
HQE I
22
NMRR-12322-11499
Rheumatology
HQE I
23
NMRR-12419-12390
Oncology
HWKKS
24
NMRR-12715-12597
Cardiology
HQE II
25
NMRR-12914-12832
Oncology
HWKKS
Observational Study :
Patient registry/Clinical
database
Observational Study :
Patient registry/Clinical
database
Interventional Study :
Clinical Trial
Interventional Study :
Clinical Trial
Interventional Study :
Clinical Trial
Interventional Study :
Clinical Trial
Interventional Study :
Clinical Trial
Interventional Study :
Clinical Trial
Interventional Study :
Clinical Trial
Interventional Study :
Clinical Trial
Interventional Study :
Clinical Trial
ISSUE 3: September – December 2013
26
NMRR-12690-13000
NMRR-12770-13097
Cardiology
HQE II
O&G
HWKKS
28
NMRR-12826-13119
PSY
HMBP
29
NMRR-12900-13137
Haematology
HQE I
30
NMRR-121102-13587
Cardiology
HQE II
31
NMRR-121096-13654
Oncology
HWKKS
33
NMRR-121071-13841
Rheumatology
HQE I
34
NMRR-121283-14486
Oncology
HWKKS
35
NMRR-13-5814559
Opthalmology
HQE I
36
NMRR-13-5414597
Pediatrics
HWKKS
37
NMRR-13127-14699
Oncology
HWKKS
27
CRC Sabah Newsletter
patients with metastatic her2-negative, met-positive
Gastroesophageal cancer
Asian Sudden Cardiac Death in Heart Failure (ASIAN-HF)
Prospective Observational Registry
A Phase III Clinical Trial to Study the Tolerability and
Immunogenicity of V503, a Multivalent Human
Papillomavirus (HPV) L1 Virus-Like Particle (VLP)
Vaccine, in 16- to 26-Year-Old Men and 16- to 26-YearOld Women
A Phase 3, Multicentre, Randomized, Double-blind,
Placebo-controlled Trial to Evaluvate the Efficacy,
Safety, and Tolerability of Brexpiprazole(OPC-34712) as
Maintenance Treatment in Adults with Schizophrenia
A randomized, open-label, multi-centre study to
evaluate patient preference with subcutaneous
administration of rituximab versus intravenous
rituximab in previously untreated patients with cd20+
diffuse large b-cell lymphoma or cd20+ follicular nonHodgkin's lymphoma grades 1, 2 or 3a
A Randomized, Double-Blind, Placebo-Controlled,
Parallel-Group Study to Evaluate the Effect of
SAR236553/REGN727 on the ocurrence of
Cardiovascular Events in Patients Who Have Recently
Experienced an Acute Coronary Syndrome
A double-blind, placebo-controlled, randomized,
multicenter phase iii study evaluating the efficacy and
safety of Pertuzumab in combination with Trastuzumab
and chemotherapy in patients with her2-positive
metastatic Gastroesophageal junction and gastric
cancer
A Randomized, Double-Blind, Placebo-Controlled 52Week Study to Assess Adverse Events of Special
Interest in Adults with Active, Autoantibody- Positive
Systemic Lupus Erythematosus Receiving Belimumab
A phase IIIb, multi-center, open-label, expanded access
study of Everolimus (RAD001) in combination with
Exemestane in post-menopausal women with Estrogen
receptor positive, human epidermal growth factor
receptor 2 negative locally advanced or metastatic
breast cancer EVEREXES
"Prospective, double-blind, placebo-controlled,
randomized, parallel-group, multi-center study with an
open-label extension period to investigate the efficacy
and safety of two different doses of NT 201 in
Botulinum toxin treatment-naïve subjects with
Blepharospasm"
Understanding Adherence, Stigma, and Behavioral Risk
Factors of Adolescents in the TREAT Asia Pediatric HIV
Observational Database using an Audio ComputerAssisted Self Interview (TApHOD ACASI)
A three-arm, randomized, open label, phase II study of
Everolimus in combination with Exemestane versus
Everolimus alone versus Capecitabine in the treatment
of postmenopausal women with estrogen receptor
positive, locally advanced, recurrent, or metastatic
Observational Study :
Clinical Epidemiology
Interventional Study :
Clinical Trial
Interventional Study :
Clinical Trial
Interventional Study :
Clinical Trial
Interventional Study :
Clinical Trial
Interventional Study :
Clinical Trial
Observational Study :
Clinical Economics
Interventional Study :
Clinical Trial
Interventional Study :
Clinical Trial
Observational Study :
Patient registry/Clinical
database
Interventional Study :
Clinical Trial
ISSUE 3: September – December 2013
38
NMRR-13197-14838
Gen Medical
Keningau
Hospital
39
NMRR-13-9615078
Gen Medical
Keningau
Hospital
CRC Sabah Newsletter
breast cancer after recurrence or progression on prior
letrozole or anastrozole
An International Survey on Hypoglycaemia among
Insulin-treated Patients with Diabetes - Non
Interventional study
DiabCare Asia 2012 - Malaysia
A Cross-Sectional Survey to Evaluate Diabetes
Management, Control, Complications, Psychosocial
Aspects of patients with type 2 diabetes in Malaysia
Non-Interventional study
Observational Study :
Patient registry/Clinical
database
Observational Study :
Clinical Epidemiology
ISSUE 3: September – December 2013
CRC Sabah Newsletter
Activities and Photo Gallery
SABAH RESEARCH DAY 2013
Sabah Research Day 2013 : The Secretariat
Opening CRC Building by
Datuk Dr Jeyaindran Tan Sri Sinnadurai
18 Oct 2013
Sabah Research Day 2013 : The Speakers
Opening Ceremony Sabah Research Day
2013 by Datuk Dr Jeyaindran Tan Sri
Sinnadurai
18 Oct 2013.
Poster Visit by Datuk Dr Jeyaindran
ISSUE 3: September – December 2013
CRC Sabah Newsletter
Sabah Research Day 2014 Participants
CRC DISTRICT VISIT
Objective: To promote CRC services and to attempt resolve problems in regards to research matters in
districts.
CRC District Visit
HOSPITAL RANAU
Date: 06 November 2013
CRC District Visit
HOSPITAL TAMBUNAN
Date: 07 November 2013
Total Participants: 29
Total Participant: 24
ISSUE 3: September – December 2013
CRC Sabah Newsletter
CRC District Visit
HOSPITAL PAPAR
Date: 12 November 2013
Total Participants: 13
CRC District Visit
HOSPITAL TUARAN
Date: 03 December 2013
NCCR 3-5 SEPT 2013, HOTEL SERI PACIFIC, KUALA LUMPUR
Total Participants: 15
ISSUE 3: September – December 2013
CRC Sabah Newsletter
RESEARCH CAMP ALUMNI 5 SEPT 2013, HOTEL SERI PACIFIC, KUALA LUMPUR
KURSUS PENGENDALIAN SAMPEL MAKMAL (7 NOV 2013), MAKMAL PATOLOGI HQE ll
COLLABORATION MEETTING BETWEEN SPU, UMS and CRC Sabah (21 Nov 2013), UMS Block, QEH
ISSUE 3: September – December 2013
CRC Sabah Newsletter
LAWATAN SAMBIL BELAJAR KE CRC HWKKS 15 NOV 2013
CRC HWKKS APPRECIATION AND CHRISTMAS LUNCH, (21ST DECEMBER 2013)
SOUL OUT RESTAURANT, GRAND BORNEO HOTEL
ISSUE 3: September – December 2013
CRC Sabah Newsletter
CONTACT US
RESEARCH CONSULTATION CLINIC
Clinical Research Centre
Hospital Queen Elizabeth I
Locked Bag No 2029
88586 Kota Kinabalu
Sabah
Tel: 088-517507
Fax: 088-211906
Email: [email protected]
Provide consultation services to facilitate researchers in:
Clinical Research Centre
Level 5, Cardiology Clinic
Hospital Queen Elizabeth II
Lorong Bersatu
Off Jalan Damai Luyang
88300 Kota Kinabalu
Sabah
Tel: 088-324600(2019)
Fax: 088-272454
Clinical Research Centre,
7th Floor, Pusat Perubatan Nuklear dan
Radioterapi,
Hospital Wanita dan Kanak-kanak
Sabah (Hospital Likas),
88996 Kota Kinabalu, sabah.
Tel:088-522600 (2272)
Fax: 088-435734
1. Research idea
 Literature search
2. Research Proposals
 Study Design
 Sample size Calculation
 Statistical analysis
3. Data analysis
4. Presentation/Publication/
Consulting services are provided at the CRC Unit. An appointment is
required, and maybe made by email or by phone:
[email protected]
[email protected]
Tel : 088-517507 or 088-324600 ext 2019
DAY
Monday
VENUE
CRC,HQE
Tuesday
CRC,HQE II
TIME
8.00am-12.00 noon
2.30pm-4.30 pm
8.00am-12.00 noon
2.30 pm- 4.30 pm
UPCOMING EVENT
1. Good Clinical Practice (GCP) Workshop collaboration with Clinical Research Malaysia
(CRM)
19th – 21st Feb 2014, Sabah Women and Children Hospital.
2. Sabah Good Clinical Practice (GCP) Workshop
26th – 28th Mar 2014, Hospital Queen Elizabeth II.
3. Basic to Intermediate Medical Biostatistics Using SPSS Workshop 2014
14 – 17 April 2014, School Of Medical, University Malaysia Sabah (UMS).
4. Advanced Medical Biostatistics Using SPSS Workshop 2014
2 – 6 Jun 2014, School Of Medical, University Malaysia Sabah (UMS).